tirzepatide surpass 4 for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Cardiovascular outcomes of semaglutide and

The problem is that weight loss is notoriously difficult to achieve particularly with lifestyle modifications, such as diet and exercise, alone

Regular physical activity is crucial for maintaining a healthy weight and preventing chronic diseases

It's all about documentation

A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities